S3V Vascular Technologies Limited
₹545▲22.47%(100.00)
About the company
S3V Vascular Technologies Limited is an Indian medical device company established in 2011 and headquartered in Mysore, Karnataka. The company specializes in developing and manufacturing innovative cardiovascular and neurovascular medical devices that support minimally invasive procedures. With a strong focus on improving patient outcomes and making advanced healthcare technologies more accessible, S3V is playing an important role in strengthening India's medical device ecosystem.
The company's product portfolio includes drug-eluting stents, PTCA balloon catheters, and a range of advanced devices designed for cardiovascular and neurovascular interventions. These products are developed to help healthcare professionals treat complex conditions such as coronary artery disease, stroke, and other vascular disorders with greater precision and efficiency. By offering high-quality, cost-effective solutions, S3V aims to reduce dependence on imported medical devices while meeting the growing demand for advanced treatment options in India.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹565 |
| 52 week low | ₹350 |
| P/B ratio | 6.99 |
| Debt to equity | 0.13 |
| ROE (%) | 0.04% |
| Book value | ₹77.97 |
| Face value | ₹10 |
52 week high
52 week low
P/B ratio
Debt
Equity
ROE (%)
| Metric | Value |
|---|---|
| 52 week high | ₹565 |
| 52 week low | ₹350 |
| P/B ratio | 6.99 |
| Debt | 11.5% of capital |
| Equity | 88.5% of capital |
| ROE (%) | 0.04% |
Registry
| Metric | Value |
|---|---|
| PAN number | AAQCS2303F |
| ISIN number | INE0HGT01012 |
Figures in cr ·
Financials
| P&L Statement | 2025Latest | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 13.5 | 15 | 19 | 21 |
| EBITDA | -0.57 | 2.5 | 3.7 | 5.8 |
| OPM | -4.22 | 16.67 | 19.47 | 27.62 |
| PBT | 0.15 | -3.06 | 0.65 | 2.8 |
| PAT | 0.06 | -3.19 | 0.56 | 2.7 |
| EPS | 0.03 | -1.66 | 0.42 | 2.08 |
Shareholding Pattern
N G Badri Narayan
Kalindhi Narayann
L&T Welfare Company Limited
N G Vijaya Gopal
N G Vishnu Shreyas
Others
| Holder | Percentage |
|---|---|
| N G Badri Narayan | 16.76% |
| Kalindhi Narayann | 8.43% |
| L&T Welfare Company Limited | 7.41% |
| N G Vijaya Gopal | 6.12% |
| N G Vishnu Shreyas | 5.05% |
| Others | 56.23% |
Leadership
Frequently asked questions
Common questions on S3V Vascular Technologies Limited—tap a row to read the answer.
Q.1What are S3V Vascular Technologies Limited unlisted shares?
S3V Vascular Technologies Limited unlisted shares are equity shares of the company that are not listed on any recognized stock exchange. These shares are traded through private, off-market transactions and are typically considered by investors looking for exposure to high-growth companies before a potential public listing.
Q.2How can I buy S3V Vascular Technologies Limited unlisted shares?
To invest in S3V Vascular Technologies Limited unlisted shares, you need a valid Demat account and access to a seller offering the shares. Once the price, quantity, and transaction terms are agreed upon, the payment is completed and the shares are transferred electronically to your Demat account through the depository system.
Q.3Is it legal to invest in S3V Vascular Technologies Limited unlisted shares in India?
Yes. Buying and selling unlisted shares is legal in India when the transaction complies with applicable regulations. The transfer should be carried out through authorized depository participants, and all required documentation should be completed to ensure a secure and valid transaction.
Q.4Do I need a Demat account to hold S3V Vascular Technologies Limited unlisted shares?
Yes. A Demat account is required to receive, hold, and transfer unlisted shares electronically. It provides a secure record of ownership and simplifies future transactions if you decide to sell your investment.
Q.5What is the minimum investment required for S3V Vascular Technologies Limited unlisted shares?
There is no fixed minimum investment amount prescribed by the company. The required investment depends on the prevailing share price, the number of shares available for purchase, and the terms agreed upon between the buyer and seller.
Q.6Is there a lock-in period after purchasing S3V Vascular Technologies Limited unlisted shares?
In most cases, there is no mandatory lock-in period for investors purchasing unlisted shares through private transactions. However, if the company is listed on a stock exchange in the future, certain regulatory lock-in provisions may apply to specific categories of shareholders under applicable SEBI regulations.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.

Unlisted Shares Price List India | Buy Pre IPO Shares Online
The Unlisted Shares Price List India helps investors track the latest prices of privately traded companies before they are listed on stock exchanges. This guide explains what Unlisted Shares and Pre IPO Shares are, how their prices are determined, and the factors that influence their valuation. It also covers the benefits, risks, taxation, and step-by-step process of buying unlisted shares in India. Additionally, the article highlights popular companies such as NSE India, OYO, API Holding (Pharm Easy), MSEI, Gamma Rotors, Zepto, Orbis Financial, and Motilal Oswal Home Finance, providing readers with a comprehensive understanding of India's growing pre-IPO market. Whether you're a new or experienced investor, this guide offers practical insights to help you make informed investment decisions.

NSE IPO Moves Closer: SEBI Approval Expected by Mid-August, Listing May Happen in September
The National Stock Exchange (NSE) IPO is moving closer to listing, with SEBI's approval for the IPO draft expected by mid-August 2026, according to NDTV Profit sources. If the remaining regulatory process is completed on time, NSE could be listed in September 2026, subject to final approvals and market conditions. A key development is the expected final settlement order in the NSE co-location case, with the settlement amount likely to exceed ₹1,400 crore. Meanwhile, NSE has reportedly begun domestic and international investor roadshows as part of its IPO preparations. While these updates indicate strong momentum toward the IPO, the final timeline remains subject to SEBI approval and official announcements.

NCDEX Launches 'Nidhi' Mutual Fund Platform: A New Chapter in India's Financial Inclusion Journey
NCDEX has launched the 'Nidhi' Mutual Fund Platform, marking a significant step toward expanding financial inclusion across rural and semi-urban India. The platform aims to simplify mutual fund investments by leveraging NCDEX's extensive FPO and agri-network, making investment opportunities more accessible to underserved communities. With six leading Asset Management Companies (AMCs) onboard at launch, the initiative seeks to encourage wider participation in India's mutual fund ecosystem and promote long-term wealth creation. Discover the key features, benefits, and potential impact of the NCDEX Nidhi Mutual Fund Platform, and learn how this strategic move strengthens NCDEX's presence beyond commodity markets while supporting the growth of India's financial ecosystem.
